Filing Flows › Tandem Diabetes Care (TNDM) › Q1 2026
Tandem Diabetes Care (TNDM) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 7, 2026
Tandem Diabetes Care (TNDM) reported revenue of $247M for the first quarter 2026 (Q1 2026), +5% from a year earlier and -15% from the quarter before. Operating margin was -7.1%, net loss $20.4M (8.2% of revenue).
Tandem Diabetes Care, Q1 2026: revenue $247M (+6% year over year), operating margin -7.1%, net loss $20.4M, operating cash flow $11.1M. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $247M | -15% | +5% |
| Operating profit | −$17.4M | -310% | — |
| Net earnings | −$20.4M | — | — |
| Operating cash flow | $11.1M | +13% | — |
| Free cash flow | $4.8M | +54% | — |
What changed
Revenue was $247.2M in Q1 2026, up 5% year over year and down 15% from the previous quarter. Supplies and other was the largest line at 55% of revenue. Pump added $8.3M year over year (up 8%), 65% of the total change.
Gross margin was 55.3%, up 4.8 points from Q1 2025. Operating costs exceeded revenue by $17.4M, an operating margin of -7.1%. Operating expenses fell 36% while revenue rose 5%. The quarter ended with a net loss of $20.4M, wider than the previous quarter's $589K loss.
Operating cash flow was $11.1M. Non-cash charges added back $4.5M of depreciation and amortization and $15.7M of share-based compensation. Working capital and other items added $11.3M. Capital expenditures of $6.3M left free cash flow of $4.8M.
Questions
What was Tandem Diabetes Care's revenue in the first quarter 2026?
Tandem Diabetes Care (TNDM) reported revenue of $247M for the first quarter 2026 (Q1 2026), +5% from a year earlier and -15% from the quarter before.
Was Tandem Diabetes Care profitable in the first quarter 2026?
Operating loss was $17.4M (-7.1% of revenue) and net loss $20.4M.